- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05184608
Cycling Dual-task in Parkinson's Disease
May 17, 2022 updated by: Iris Machado de Oliveira, University of Vigo
Effects of a Cycling Dual-task Intervention on Cognition and Functionality in Parkinson's Disease: a Pilot Randomized Clinical Trial
Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pontevedra, Spain, 36004
- University of Vigo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Parkinson disease
- Hoehn and Yahr 1 and 2
Exclusion Criteria:
- Hoehn and Yahr >2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cycling combined with cognitive tasks
|
20 minutes of cycling (90 rpm).
20 minutes of cognitive tasks based on the different domains of the UPDRS scale.
|
Active Comparator: Cycling
|
20 minutes of cycling (90 rpm).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Timed Up and Go
Time Frame: Change from Baseline Timed Up and Go at 7 weeks
|
Dynamic balance
|
Change from Baseline Timed Up and Go at 7 weeks
|
Sit to Stand test
Time Frame: Change from Baseline Sit to Stan Test at 7 weeks
|
Lower limbs strength
|
Change from Baseline Sit to Stan Test at 7 weeks
|
Movement Disorder Society - Unified Parkinson's Disease Rating Scale
Time Frame: Change from Baseline Unified Parkinson's Disease Rating Scale at 7 weeks (0-159, better lower values)
|
Parkinson's Disease rating
|
Change from Baseline Unified Parkinson's Disease Rating Scale at 7 weeks (0-159, better lower values)
|
Parkinson's Disease Questionnaire - 39
Time Frame: Change from Baseline Parkinson's Disease Questionnaire - 39 at 7 weeks (0-100, better lower values)
|
Quality of life
|
Change from Baseline Parkinson's Disease Questionnaire - 39 at 7 weeks (0-100, better lower values)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trail Making Test A & B
Time Frame: Change from Baseline Trail Making Test A & B at 7 weeks
|
Attention, visual screening ability and processing speed
|
Change from Baseline Trail Making Test A & B at 7 weeks
|
Stroop test
Time Frame: Change from Baseline Stroop Test at 7 weeks
|
Ability to inhibit cognitive interference
|
Change from Baseline Stroop Test at 7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 11, 2021
Primary Completion (Actual)
October 28, 2021
Study Completion (Actual)
January 31, 2022
Study Registration Dates
First Submitted
November 26, 2021
First Submitted That Met QC Criteria
January 7, 2022
First Posted (Actual)
January 11, 2022
Study Record Updates
Last Update Posted (Actual)
May 25, 2022
Last Update Submitted That Met QC Criteria
May 17, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020/057
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Cycling exercise
-
Université Catholique de LouvainRecruiting
-
Bispebjerg HospitalNot yet recruitingSarcopenia | Treatment Adherence and Compliance | Hospital Acquired Condition | Inactivity, PhysicalDenmark
-
Chung Shan Medical UniversityCompleted
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenRecruitingCritical Illness | Intensive Care Unit Acquired WeaknessBelgium
-
Buddhist Tzu Chi General HospitalCompletedFatigue | Sleep Disorder | Exercise | Hemolysis | AdipocytesTaiwan
-
Pacific Parkinson's Research CentreCompleted
-
University of OttawaThe Ottawa Hospital; Multiple Sclerosis Society of CanadaRecruiting
-
Mayo ClinicNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Middle East Technical UniversityCompletedOsteoarthritis | Degenerative Lesion of Articular Cartilage of Knee | Articular Cartilage Disorder of KneeTurkey
-
Nordic Bioscience A/SUniversity of Copenhagen; NBCD A/SCompleted